| Literature DB >> 28693504 |
Karuppasamy Chellapandi1,2, Tapan Kumar Dutta3, Indu Sharma2, Surajit De Mandal4, Nachimuthu Senthil Kumar4, Lalsanglura Ralte5.
Abstract
BACKGROUND: Diarrheagenic Escherichia coli are associated with infantile diarrhea in the developing countries. The present study was conducted to determine the occurrence and antimicrobial resistance pattern of enteropathogenic and enteroinvasive E. coli associated with diarrhoea among the paediatric patients.Entities:
Keywords: EIEC; EPEC; Infants; MDR; Mizoram
Mesh:
Substances:
Year: 2017 PMID: 28693504 PMCID: PMC5504610 DOI: 10.1186/s12941-017-0225-x
Source DB: PubMed Journal: Ann Clin Microbiol Antimicrob ISSN: 1476-0711 Impact factor: 3.944
Clinical symptoms of subjects included in this study
| Clinical characteristics | Total no. of subjects | EPEC | EIEC |
|---|---|---|---|
| Sex ratio | |||
| Male | 114 (43.5) | 28 (10.69) | 03 (1.14) |
| Female | 148 (56.5) | 22 (08.39) | 05 (01.91) |
| Fever | |||
| Febrile | 123 (46.9) | 34 (13.00) | 05 (01.91) |
| Afebrile | 139 (53.0) | 13 (04.96) | 02 (0.76) |
| Vomiting | 91 (34.7) | 33 (12.60) | 04 (01.52) |
| Abdominal pain | 48 (18.3) | 31 (11.80) | 05 (01.91) |
| Diarrhea and non-diarrhea | |||
| Watery stool | 158 (60.3) | 40 (15.30) | 01 (0.38) |
| Mucous | 34 (12.9) | 03 (01.15) | 02 (0.76) |
| Bloody | 18 (06.9) | 01 (0.38) | 04 (01.52) |
| No symptoms | 52 (19.84) | 03 (01.15) | – |
| Diarrheal frequency | |||
| 2–3 times a day | 180 (68.7) | 27 (10.31) | 07 (02.67) |
| 4–5 times a day | 19 (07.25) | 19 (07.25) | – |
| 5–10 times a day | 11 (04.2) | 01 (0.38) | – |
| Dehydration | |||
| Mild dehydration | 37 (14.1) | 13 (04.96) | 01 (0.38) |
| Moderate dehydration | 28 (10.7) | 14 (05.34) | – |
| Severe dehydration | 63 (24.0) | 04 (01.53) | – |
| Unknown | 134 (51.1) | 16 (06.11) | 06 (02.30) |
Within parenthesis denotes the % of the samples
EPEC enteropathogenic E. coli, EIEC enteroinvasive E. coli
Frequency of E. coli pathotypes isolated from fecal samples of children with and without diarrhea
| S. no |
|
|
| Total |
|---|---|---|---|---|
| 1. | EPEC | 12 (3.59) | 38 (11.38) | 50 (14.97) |
|
| 07 (2.10) | 22 (6.59) | 29 (8.68) | |
|
| 05 (1.50) | 16 (4.79) | 21 (6.29) | |
| 2. | EIEC | 02 (0.59) | 06 (1.80) | 08 (2.33) |
| Total | 14 (4.07) | 44 (13.17) | 58 (17.37) | |
Figures in parenthesis denotes the % of the samples
a-EPEC atypical enteropathogenic E. coli, t-EPEC typical enteropathogenic E. coli
Age wise comparison of EPEC and EIEC from the stool samples of children
| Age (months) | No. of isolates | Atypical EPEC (n = 29) | Typical EPEC (n = 21) | EIEC (n = 08) | Total (n = 334) | |||
|---|---|---|---|---|---|---|---|---|
| Age | Non age | Age | Non age | Age | Non age | |||
| 0–12 | 176 (52.69) | 07 (02.09) | 03 (0.90) | 06 (01.80) | 01 (0.30) | 03 (0.90) | 01 (0.30) | 21 (6.3) |
| 13–24 | 98 (29.34) | 11 (03.29) | – | 05 (01.50) | 03 (0.90) | 02 (0.60) | 01 (0.30) | 22 (6.6) |
| 25–36 | 37 (11.07) | 05 (01.49) | – | 01 (0.30) | 01 (0.30) | – | – | 7 (2.1) |
| 37–48 | 14 (04.19) | 01 (0.30) | – | 01 (0.30) | – | – | – | 2 (0.6) |
| 49–60 | 09 (02.69) | 02 (0.60) | – | 03 (0.90) | – | 01 (0.30) | – | 6 (1.8) |
| Total | 334 | 26 (7.8) | 03 (0.9) | 16 (4.8) | 05 (1.5) | 06 (1.8) | 02 (0.5) | 58 (17.4) |
Figures in parenthesis denotes the % of the samples
AGE acute gastroenteritis, EPEC enteropathogenic E. coli, EIEC enteroinvasive E. coli
Seasonal distribution of diarrheagenic E. coli among children
| Seasons |
| ‘O’ Serotypes (no. of isolates) | EPEC | EIEC (%) | Total | |
|---|---|---|---|---|---|---|
| Atypical (%) | Typical (%) | |||||
| Summer | 138 | EPEC (22): O2 (1), O26 (2), O84 (1), O86 (2), O91 (1), O116 (1), O 129 (1), O141 (4), O145 (1), O149 (3), Rough (2), UT (3) | 12 (3.59) | 10 (2.99) | 05 (1.5) | 27 (8.08) |
| EIEC (05): O29 (1), O96 (2), O124 (1) UT (1) | ||||||
| Rainy/autumn | 96 | EPEC (16): O2 (1), O 29 (1), O 83 (1), O84 (3), O86 (2), O91 (1), O126 (1), Rough (4), UT (2) | 10 (2.99) | 06 (1.8) | 01 (0.3) | 17 (5.09) |
| EIEC (01): UT (01) | ||||||
| Winter | 100 | EPEC (12): O 2 (1), O 35 (1), O83 (1), O 101 (1), O126 (2), O 145 (2), O 149 (1), Rough (1), UT (2) | 07 (2.1) | 05 (1.5) | 02 (0.6) | 14 (4.19) |
| EIEC (02): O20 (1), O144 (1) | ||||||
| Total | 334 | 58 | 29 (8.68) | 21 (6.29) | 08 (2.4) | 58 (17.37) |
Figures in parenthesis denotes the % of the samples
EPEC enteropathogenic E. coli, EIEC enteroinvasive E. coli
Antimicrobial resistance profile of diarrheagenic E. coli isolated from stool samples collected from children
| DEC (n) | AMP | AK | C | CN | CI | CF | COT | CST | MRP | NX | G | CFM | DO | OF | MDR (%) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| a-EPEC (29) | 21 (72.4) | 06 (20.7) | 14 (48.3) | 14 (48.3) | 22 (75.9) | 10 (34.5) | 09 (31.0) | 24 (82.8) | 06 (20.7) | 12 (41.4) | 04 (13.8) | 21 (72.4) | 12 (41.4) | 14 (48.3) | 14 (48.3) |
| t-EPEC (21) | 14 (66.7) | 08 (38.1) | 05 (23.8) | 12 (57.1) | 12 (57.1) | 03 (14.3) | 08 (38.1) | 16 (76.2) | 06 (28.6) | 09 (42.6) | 07 (33.3) | 12 (57.1) | 12 (57.1) | 07 (33.3) | 07 (24.1) |
| EIEC (08) | 07 (87.5) | 01 (12.5) | 00 (0) | 06 (75) | 07 (87.5) | 04 (50) | 07 (87.5) | 04 (50) | 05 (62.5) | 01 (12.5) | 05 (62.5) | 05 (62.5) | 05 (62.5) | 05 (62.5) | 03 (37.5) |
| Total (58) | 42 (72.4) | 15 (25.9) | 19 (32.8) | 32 (55.2) | 41 (70.7) | 17 (29.3) | 24 (41.4) | 44 (75.9) | 17 (29.3) | 22 (37.9) | 16 (27.6) | 38 (65.5) | 29 (50) | 26 (44.8) | 24 (41.4) |
Figures in parenthesis denotes the % of the samples
MDR multi drug resistant, a-EPEC atypical enteropathogenic Escherichia coli, t-EPEC typical enteropathogenic Escherichia coli, EIEC enteroinvasive Escherichia coli, μg microgram, Antibiotics ampicillin (AMP10 = 10 μg), amikacin (AK10 = 10 μg), chloramphenicol (C 30 = 30 μg), ceftriaxone (CI 10 = 10 μg), cephalexin (CN30 = 30 μg), ciprofloxacin (CF10 = 10 μg), co-trimoxazole (COT25 = trimethoprim 1.25 μg and sulphamethoxazole 23.75 μg), cefoperazone–tazobactam (CST 75–10 μg), meropenem (MRP10 = 10 μg), norfloxacin (NX10 = 10 μg), gentamicin (G10 = 10 μg), cefixime (CFM 5 = 5 μg), doxycycline hydrochloride (DO10 = 10 μg) and ofloxacin (OF 5 = 5 μg)